👨⚕️ Medical Team
DOZA weight-management programme specialists
DOZA is a weight-management programme service: specialist screening and in-programme support. An endocrinologist or gastroenterologist is an in-person referral when the case needs it, not a staff substitute for an exam. This is the E-E-A-T foundation (experience, expertise, authoritativeness, trust) of our work with approved GLP-1, branded analogs, and research programmes.
Valentyna Tytorenko
Diploma-certified endocrinologist, certified dietitian and nutritionist
In medicine since 2017
Provides paid tirzepatide-course support for DOZA clients: lab review, dose titration per the manufacturer schedule, nutrition and deficiency correction.
- Tirzepatide course support (GLP-1/GIP)
- Lab results review
- Dose titration per manufacturer schedule
- Dietetics and nutrition: diet and deficiency correction
- Pediatric endocrinology (qualification)
Melnyk Natalia
Gastroenterologist
10 years of experience
GI tract diagnostics and correction during the program. Individual nutrition recommendations.
- GI tract functional disorders
- GLP-1 program adaptation
- Nutritiology
Savchenko Dmytro
Endocrinologist
7 years of experience
Specializes in obesity and metabolic disorders. Individual weight correction program selection considering hormonal profile.
- Obesity and metabolic syndrome
- Hormonal diagnostics
- Insulin resistance
Olena Kovalchuk
Medical Reviewer, Endocrinologist
10+ years of clinical experience
Verifies accuracy of medical information on doza.clinic. Specializes in GLP-1 agonists and metabolic disorders.
- GLP-1/GIP agonists (tirzepatide, semaglutide)
- Metabolic syndrome and obesity
- Peptide therapy
- Medical content review
Iryna Bondarenko
Content Specialist, Nutrition Science
6+ years in medical journalism
Writes and edits DOZA blog articles, translating complex clinical data into accessible content. Certified nutritionist.
- Medical journalism
- Nutrition science and dietetics
- Evidence-based medical content
- SEO for medical materials
How the team supports each product category
- Approved (Ozempic, Mounjaro): full clinical support — initial consultation, dose titration, side-effect monitoring, scheduled review every 4 weeks.
- Branded analog (Biopatid by Biopell Medical): the same support protocol plus transparent disclosure that this is a third-party manufactured product.
- Investigational Phase 3 (Retatrutide, Cagrilintide): dedicated medical consultation with mandatory disclosure of "not yet registered" status, risk assessment, and monitoring.
- Research-grade peptides: educational support, links to the scientific database, recommendations from nutritionist physicians.
🏛️ Research Policy
How DOZA distinguishes approved, compounded, investigational, and research-grade products
◐ About DOZA
Founding story, values, and support methodology